Old Web
English
Sign In
Acemap
>
authorDetail
>
I. Gómez Estévez
I. Gómez Estévez
Medicine
Natalizumab
Pandemic
Prospective cohort study
Internal medicine
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
COVID-19 infection and vaccination in patients with multiple sclerosis during COVID pandemic
2021
European Journal of Neurology
Celia Oreja-Guevara
E. Martínez Pérez
I. Gómez Estévez
C I Ramirez
Judit Diaz-Diaz
Show All
Source
Cite
Save
Citations (0)
Effect of cladribine on COVID-19 serology responses following 2 doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis
2021
Multiple Sclerosis Journal
Judit Diaz-Diaz
C I Ramirez
E. Garcia-Yusta
M. Ortiz-Pica
E. Martínez Pérez
I. Gómez Estévez
Celia Oreja-Guevara
Show All
Source
Cite
Save
Citations (0)
MS patients treated with natalizumab during the COVID-19 pandemic: Safety and management
2021
European Journal of Neurology
J. Díaz Díaz
Claudio Ramirez
M. Ortiz-Pica
I. Gómez Estévez
E. Garcia-Yusta
C.Oreja Guevara
Show All
Source
Cite
Save
Citations (0)
Is natalizumab a safe treatment for patients with multiple sclerosis in the COVID-19 pandemic? Data from the first year of the pandemic
2021
Multiple sclerosis and related disorders
J. Díaz Díaz
C I Ramirez
M. Ortiz-Pica
E. Garcia-Yusta
I. Gómez Estévez
C.Oreja Guevara
Show All
Source
Cite
Save
Citations (0)
COVID-19 vaccination and humoral immune response in people with multiple sclerosis
2021
Multiple Sclerosis Journal
Celia Oreja-Guevara
C I Ramirez
E. Alba-Suarez
I. Gómez Estévez
C. Bullón Sánchez
M. Castro-Hernandez
E. Martínez Pérez
Judit Diaz-Diaz
Show All
Source
Cite
Save
Citations (0)
1